Syros Pharmaceuticals Inc.
SYRS
Market Cap$590.32K
Close$
$6.67
23318.6% upside
Current Fair Value
23318.6% upsideUndervalued by 23318.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $590,315.00 |
|---|---|
| Enterprise Value | $-38,539,685.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.81 |
| Beta | 1.56 |
| Outstanding Shares | 39,269,434 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | -99.84 |
| Enterprise Value to EBIT | 0.35 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.5 |
| Debt to Equity | -1.72 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Syros Pharmaceuticals Inc.
CEO: Nancy Simonian